Increased registration of hypertension and cancer diagnoses after the introduction of a new reimbursement system

被引:10
|
作者
Hjerpe, Per [1 ,2 ]
Bostrom, Kristina Bengtsson [1 ]
Lindblad, Ulf [3 ]
Merlo, Juan [2 ]
机构
[1] Skaraborg Primary Care, R&D Ctr, Skovde, Sweden
[2] Lund Univ, Dept Clin Sci Malmo, Fac Med, S-22100 Lund, Sweden
[3] Gothenburg Univ, Dept Publ Hlth & Community Med Primary Hlth Care, Sahlgrenska Acad, S-41124 Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Electronic health records; general practice; ICD codes; incentive; multilevel analysis; primary health care; reimbursement; Sweden; BRIEF CONCEPTUAL TUTORIAL; SWEDISH PRIMARY-CARE; MULTILEVEL ANALYSIS; SOCIAL EPIDEMIOLOGY; HEALTH; SWEDEN;
D O I
10.3109/02813432.2012.735552
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To investigate the impact on ICD coding behaviour of a new case-mix reimbursement system based on coded patient diagnoses. The main hypothesis was that after the introduction of the new system the coding of chronic diseases like hypertension and cancer would increase and the variance in propensity for coding would decrease on both physician and health care centre (HCC) levels. Design. Cross-sectional multilevel logistic regression analyses were performed in periods covering the time before and after the introduction of the new reimbursement system. Setting. Skaraborg primary care, Sweden. Subjects. All patients (n = 76 546 to 79 826) 50 years of age and older visiting 468 to 627 physicians at the 22 public HCCs in five consecutive time periods of one year each. Main outcome measures. Registered codes for hypertension and cancer diseases in Skaraborg primary care database (SPCD). Results. After the introduction of the new reimbursement system the adjusted prevalence of hypertension and cancer in SPCD increased from 17.4% to 32.2% and from 0.79% to 2.32%, respectively, probably partly due to an increased diagnosis coding of indirect patient contacts. The total variance in the propensity for coding declined simultaneously at the physician level for both diagnosis groups. Conclusions. Changes in the healthcare reimbursement system may directly influence the contents of a research database that retrieves data from clinical practice. This should be taken into account when using such a database for research purposes, and the data should be validated for each diagnosis.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 50 条
  • [41] New system mops up cancer cells after brain tumour surgery
    Orellana, Claudia
    LANCET ONCOLOGY, 2001, 2 (06): : 330 - 330
  • [42] Increased Detectability of Plasma HIV-1 RNA after Introduction of a New Assay and Altered Specimen-Processing Procedures
    Rebeiro, Peter F.
    Kheshti, Asghar
    Bebawy, Sally S.
    Stinnette, Samuel E.
    Erdem, Husamettin
    Tang, Yi-Wei
    Sterling, Timothy R.
    Raffanti, Stephen P.
    D'Aquila, Richard T.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (10) : 1354 - 1357
  • [43] Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
    Storas, Anne Holck
    Fossa, Sophie D.
    Ursin, Giske
    Andreassen, Bettina Kulle
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 53 - 58
  • [44] Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
    Anne Holck Storås
    Sophie D. Fosså
    Giske Ursin
    Bettina Kulle Andreassen
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 53 - 58
  • [45] Patient-reported perceptions of care after the introduction of a new advanced cancer nursing role in Sweden
    Westman, B.
    Ullgren, H.
    Olofsson, A.
    Sharp, L.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2019, 41 : 41 - 48
  • [46] The Review of New Drug Applications in Japan: The Decline in Approval Times after the Introduction of an Internalized Review System
    Shunsuke Ono
    Chisato Yoshioka
    Orie Asaka
    Koji Tamura
    Drug information journal : DIJ / Drug Information Association, 2005, 39 (3): : 279 - 290
  • [47] The review of new drug applications in Japan: The decline in approval times after the introduction of an internalized review system
    Ono, S
    Yoshioka, H
    Asaka, O
    Tamura, K
    DRUG INFORMATION JOURNAL, 2005, 39 (03): : 279 - 290
  • [48] Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
    Masami Arai
    Shiro Yokoyama
    Chie Watanabe
    Reiko Yoshida
    Mizuho Kita
    Megumi Okawa
    Akihiro Sakurai
    Masayuki Sekine
    Junko Yotsumoto
    Hiroyuki Nomura
    Yoshinori Akama
    Mayuko Inuzuka
    Tadashi Nomizu
    Takayuki Enomoto
    Seigo Nakamura
    Journal of Human Genetics, 2018, 63 : 447 - 457
  • [49] Evaluating the Use of an Electronic Death Registration System for Mortality Surveillance During and After Hurricane Sandy: New York City, 2012
    Howland, Renata E.
    Li, Wenhui
    Madsen, Ann M.
    Wong, Howard
    Das, Tara
    Betancourt, Flor M.
    Nicaj, Leze
    Stayton, Catherine
    Matte, Thomas
    Begier, Elizabeth M.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (11) : E55 - E62
  • [50] The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature
    A. Offermann
    M. C. Hupe
    V. Sailer
    A. S. Merseburger
    S. Perner
    World Journal of Urology, 2020, 38 : 657 - 662